Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 190

1.

[Severe tricyclic antidepressants poisoning--a case study].

Zapalska-Pozarowska K, Szponar J, Tchórz M, Kostek H, Pozarowski W.

Przegl Lek. 2012;69(8):621-3. Polish.

PMID:
23243947
2.

Tricyclic antidepressants, QT interval prolongation, and torsade de pointes.

Vieweg WV, Wood MA.

Psychosomatics. 2004 Sep-Oct;45(5):371-7.

PMID:
15345781
3.

[QT prolongation and torsade de pointes tachycardia during therapy with maprotiline. Differential diagnostic and therapeutic aspects].

Lentini S, Rao ML, Schröder R, Lüderitz B, Bauriedel G.

Dtsch Med Wochenschr. 2001 Dec 7;126(49):1396-400. German.

PMID:
11740632
4.

[Drug induced QT prolongation].

Altmann D, Eggmann U, Ammann P.

Wien Klin Wochenschr. 2008;120(5-6):128-35. doi: 10.1007/s00508-008-0940-6. Review. German.

PMID:
18365152
5.

Pharmacokinetic-pharmacodynamic modelling of QT interval prolongation following citalopram overdoses.

Friberg LE, Isbister GK, Duffull SB.

Br J Clin Pharmacol. 2006 Feb;61(2):177-90.

6.
7.

Current concepts in the mechanisms and management of drug-induced QT prolongation and torsade de pointes.

Gupta A, Lawrence AT, Krishnan K, Kavinsky CJ, Trohman RG.

Am Heart J. 2007 Jun;153(6):891-9. Review.

PMID:
17540188
8.

Medical toxicologists' practice patterns regarding drug-induced QT prolongation in overdose patients: a survey in the United States of America, Europe, and Asia Pacific region.

Othong R, Devlin JJ, Kazzi ZN.

Clin Toxicol (Phila). 2015 May;53(4):204-9. doi: 10.3109/15563650.2015.1013547. Epub 2015 Feb 23.

PMID:
25706450
9.
10.

A case of torsades de pointes induced by severe QT prolongation after an overdose of eperisone and triazolam in a patient receiving nifedipine.

Yamagiwa T, Amino M, Morita S, Yamamoto R, Saito T, Inokuchi S.

Clin Toxicol (Phila). 2010 Feb;48(2):149-52. doi: 10.3109/15563650903524126.

PMID:
20199131
12.

Risk factors for QT prolongation associated with acute psychotropic drug overdose.

Miura N, Saito T, Taira T, Umebachi R, Inokuchi S.

Am J Emerg Med. 2015 Feb;33(2):142-9. doi: 10.1016/j.ajem.2014.09.048. Epub 2014 Oct 5.

PMID:
25445869
13.

Prolonged QT Risk Assessment in Antipsychotic Overdose Using the QT Nomogram.

Berling I, Isbister GK.

Ann Emerg Med. 2015 Aug;66(2):154-64. doi: 10.1016/j.annemergmed.2014.12.005. Epub 2015 Jan 30.

PMID:
25639523
14.

Amisulpride overdose is frequently associated with QT prolongation and torsades de pointes.

Isbister GK, Balit CR, Macleod D, Duffull SB.

J Clin Psychopharmacol. 2010 Aug;30(4):391-5. doi: 10.1097/JCP.0b013e3181e5c14c.

PMID:
20531221
15.

Antidepressants: their effects on cardiac channels, QT prolongation and Torsade de Pointes.

Sala M, Coppa F, Cappucciati C, Brambilla P, d'Allio G, Caverzasi E, Barale F, De Ferrari GM.

Curr Opin Investig Drugs. 2006 Mar;7(3):256-63. Review.

PMID:
16555686
16.

Torsade de pointes induced by terfenadine in a patient with long QT syndrome.

Koh KK, Rim MS, Yoon J, Kim SS.

J Electrocardiol. 1994 Oct;27(4):343-6.

PMID:
7815014
17.

[Torsade de pointes].

Haverkamp W, Hördt M, Chen X, Hindricks G, Willems S, Kottkamp H, Rotman B, Brunn J, Borggrefe M, Breithardt G.

Z Kardiol. 1993 Dec;82(12):763-74. Review. German.

PMID:
8147050
18.

Pause-dependent torsade de pointes following acute myocardial infarction: a variant of the acquired long QT syndrome.

Halkin A, Roth A, Lurie I, Fish R, Belhassen B, Viskin S.

J Am Coll Cardiol. 2001 Oct;38(4):1168-74.

19.

Torsade de pointes. Mechanisms and management.

Napolitano C, Priori SG, Schwartz PJ.

Drugs. 1994 Jan;47(1):51-65. Review.

PMID:
7510621
20.

Prolonged QT interval and torsades de pointes caused by the combination of fluconazole and amitriptyline.

Dorsey ST, Biblo LA.

Am J Emerg Med. 2000 Mar;18(2):227-9. No abstract available.

PMID:
10750939

Supplemental Content

Support Center